Source disclosure: February 13, 2026
HOGY MEDICAL CO.,LTD. [3593.T]
TOKYO, Feb 13 (Reuters) - TCG2509 Co., Ltd. has announced an amendment to its tender offer for common shares of Hogy Medical Co., Ltd. (code number 3593), listed on the Tokyo Stock Exchange Prime Market. The revised terms follow adjustments made due to changes under the Foreign Exchange and Foreign Trade Act that shortened the waiting period required by law.
The original tender offer was initiated on December 18, 2025, with subsequent amendments filed on December 25, 2025, January 6, 2026, and February 5, 2026. Due to legal modifications allowing earlier acquisition of shares, TCG2509 submitted a corrected tender offer filing to the Kanto Finance Bureau Director on February 13, 2026. As a result, the tender offer period is now extended until March 2, 2026, marking a total duration of 45 trading days from the date of submission.
Hogy Medical Co., Ltd., led by President Shuji Kawakubo, will continue to be subject to this tender offer process.
This announcement follows the company's initial disclosure dated December 17, 2025, which underwent several revisions over the past months. The latest revision includes updates to both the tender offer document and the public notice issued on December 18, 2025. These documents have been amended according to Article 27-8 Paragraph 2 of the Financial Instruments and Exchange Law, necessitating the correction of certain information previously disclosed.
TCG2509, represented by Chairman Gen'ei Saito, decided during its board meeting held on December 17, 2025, to proceed with acquiring ordinary shares of Hogy Medical through a public tender offer. This decision was based on the company’s strategic assessment and regulatory compliance requirements. With the recent legal adjustments shortening the mandatory waiting period, TCG2509 has taken steps to extend the tender offer period accordingly, ensuring all stakeholders are informed of these changes.
AI-translated content. 🟢 Confidence: High See terms • Original filing